Thank you for your entry in the "Guess the CR date" competition.
I agree that we'll hear about FTO in humans when the Sheba 2 results are announced. But I think that we won't hear about the CDx until it's actually used.
I also agree that running the cardioprotection trial in the USA has merits and that the only disadvantages are the cost and R&D rebate not available.
But COH can't run any trial for RAC because:
* their lawyers would want COH to own part or all of the IP
* it's too dangerous to give COH any argument to bolster their case that they own CS1.
RAC media coverage, page-1202
-
- There are more pages in this discussion • 1,084 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.000(0.00%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.95 | $1.95 | $1.84 | $647.3K | 344.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3300 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.94 | 5654 | 2 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |